Gala Dinner 2018

We are delighted that our 2018 Gala Dinner attending organisations included:


AbbVie Covington & Burling Mereo BioPharma
Abcodia Desktop Genetics Mission Therapeutics
Abingworth Diurnal Group Nodthera Limited
ABPI Eli Lilly Numis Securities Limited
Abzena Eli Lilly and Company One Nucleus
Achilles Therapeutics Endomag One Ventures
Achilles Therapeutics Epidarex Orchard Therapeutics
Advanced medical Solutions Evotec Owlstone Medical
Advent Life Sciences Exscientia Oxford BioMedica
Albion Capital Fieldfisher Oxford Genetics
Alzheimer's Research UK Finnegan Europe OxStem
Amici Procurement Solutions Finnegan, Henderson, Farabow, Garrett & Dunner Panmure Gordon
Apollo Therapeutics Freeline Therapeutics Phico Therapeutics
Arecor Freeline Therapeutics Limited Potter Clarkson
Arnold & Porter F-Star Biotechnology PTC Therapeutics International Limited
Artios Pharma FTI Consulting Puridify
Ashfield Healthcare Fujifilm Diosynth Biotechnologies. Quanta Diaylsis Technologies
Astex Pharmaceuticals Galapagos NV QuantuMDx Group
AstraZeneca Galvani Bioelectronics Queen Mary University of London
AstraZeneca GammaDelta Therapeutics Reneuron
Atlantic Pharmaceuticals GE Healthcare Life Sciences Repositive
Autifony Therapeutics Genomics RexGenero
Autifony Therapeutics Genomics England Rothschild
Autolus Genomics Ireland S&P Global Market Intelligence
Autolus GlaxoSmithKline Sanofi
Autolus Limited GlaxoSmithKline Pharmaceuticals Sanofi
Avillion Globe Life Sciences Sanofi (Sunrise)
Azul Optics Limited/University of Bristol Glythera Limited Sanofi Genzyme
Babraham Bioscience Technologies Gowling WLG Scancell
Babraham Institute GSK School of Life Sciences, University of Dundee
Bayer GSK & CIPA SenzaGen AB
BBSRC GW Pharmaceuticals Silicon Valley Bank
Bicycle Therapeutics Gyroscope Therapeutics Limited Simmons & Simmons
Biogen Idec Hargreave Hale Simmons & Simmons
Bristol-Myers Squibb HealthCor Partners Sinclair Pharma
Bristows Horizon Discovery Group Sirakoss Limited
BTG Illumina SomaNautix
BTG International Immatics Summit Therapeutics
Calchan Immunocore SV Health Investors
Calcico  Imperial Innovations SV Life Sciences Managers
Cambridge Cancer Genomics Imperial ThinkSpace Syncona
Cambridge Enterprise , University of Cambridge Inflazome Syncona
Cambridge Innovation Capital Inivata Taylor Wessing
Cambridge University Entreprenuers Innovate UK Teva
Cancer Research Technology InnovateUK The Institute of Cancer Research
Cancer Research UK Investec The Sunday Times
Cancer Research UK IP Group Topas Therapeutics
Cancer Research UK/ UK Research and Innovation Isogenica Touchstone Innovation  
Capital Access Group Istesso Tusk Therapeutics
Capital Cell Ixico TVM Capital Life Science’s
Carrick Therapeutics J&J UCB
Carrick Therapeutics Johnson & Johnson UCB Celltech
Celixir Johnson & Johnson Innovation UCL Business
Celixir Johnson and Jonson Innovation UCL Innovation and Enterprise
Cell and Gene Therapy Catapult KDH Biomanagement Unilever
Cell Medica Kymab University College London
Cell Medica Limited Kymab Limited University of Cambridge
Censo Biotechnologies Lansdowne Partners University of Oxford
China Medical System Holdings LifeArc (formerly MRC Technology) Vectura
CMS Manentia Vectura Limited
CN Bio Innovations Median Technologies Virion Health
Cobra Biologics Medicines Discovery Catapult Wellcome Trust
Consilium Strategic Communications Medicxi  
Convergence MedImmune  
Cooley Merck Ventures